Hinge Health Inc（HNGE）の財務HNGEHinge Health Inc

Evaluating the bottom line, Hinge Health, Inc. maintains a gross margin of 86.44%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.00%, while the net margin is 20.53%. These profitability ratios, combined with a Return on Equity (ROE) of 41.41%, provide a clear picture of how effectively HNGE converts its operational activities into shareholder value.

In the context of the broader market, HNGE competes directly with industry leaders such as PL and DUOL. With a market capitalization of $7.14B, it holds a significant position in the sector. When comparing efficiency, HNGE's gross margin of 86.44% stands against PL's 53.53% and DUOL's 72.62%. Such benchmarking helps identify whether Hinge Health, Inc. is trading at a premium or discount relative to its financial performance.

Hinge Health's revenue has shown consistent growth, with Q2 2026 revenue at $213 million, up 53% year-over-year. The gross margin has also improved, reaching 86.44% in Q2 2026, reflecting strong operational efficiency.